RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Realcan Pharmaceutical Group Co Stock

Realcan Pharmaceutical Group Co ROA 2024

Realcan Pharmaceutical Group Co ROA

0

Ticker

002589.SZ

ISIN

CNE1000013X5

In 2024, Realcan Pharmaceutical Group Co's return on assets (ROA) was 0, a -101.22% increase from the -0.1 ROA in the previous year.

Realcan Pharmaceutical Group Co Aktienanalyse

What does Realcan Pharmaceutical Group Co do?

Realcan Pharmaceutical Group Co. Ltd is a Chinese pharmaceutical company based in the city of Chengdu. The company was founded in 2009 and has since built a deep knowledge and understanding of the pharmaceutical industry in the Chinese market. Since its inception, the company has developed a wide range of drugs and health products. Realcan Pharmaceutical Group Co. Ltd has established itself as one of the largest and most reliable pharmaceutical companies in China, specializing in the development, manufacturing, and marketing of pharmaceuticals. The business model of Realcan Pharmaceutical Group Co. Ltd is based on a variety of growth drivers, including entering new markets and developing new products. The company has always focused on leveraging the experience and expertise of its employees to deliver innovations and high-quality products that have a positive impact on consumer health. The company places the highest value on the quality, safety, and effectiveness of its products and services. Realcan Pharmaceutical Group Co. Ltd offers a wide range of products, ranging from drugs and medications to health products and supplements. The company specializes in various areas, including oncology, dermatology, cardiology, neurology, respiratory diseases, gastroenterology, and endocrinology. Several products from Realcan have already received approval from the Chinese health authority and are available on the market. Some of the company's most well-known products include the anti-tumor drugs Nifuratel and Nifuratrone, the cardiology product Cardio Protect, and the neurology product Neuro Relief. Realcan Pharmaceutical Group Co. Ltd also specializes in the production of traditional Chinese medicine and herbal medicine. Traditional Chinese medicine is gaining increasing importance in the Chinese market as it is considered an effective alternative to Western medicine. Realcan Pharmaceutical Group Co. Ltd is committed to promoting research and development in the field of traditional Chinese medicine. The company works closely with universities and other research institutions to develop effective and safe herbal medicine. Realcan Pharmaceutical Group Co. Ltd also specializes in entering international markets. The company exports its products to various countries, including the United States, Australia, France, India, and Japan. The company places great emphasis on complying with international standards and ensuring the safety and quality of its products. In summary, Realcan Pharmaceutical Group Co. Ltd is an innovative Chinese pharmaceutical company that offers a wide range of pharmaceutical products and services. The company has established itself as a reliable brand in the field of drug development and manufacturing and is committed to adhering to global standards to strengthen customer trust. Realcan Pharmaceutical Group Co. Ltd will continue to play an important role in the Chinese and international markets and consolidate its leadership position as a reliable and innovative pharmaceutical company. Realcan Pharmaceutical Group Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Realcan Pharmaceutical Group Co's Return on Assets (ROA)

Realcan Pharmaceutical Group Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Realcan Pharmaceutical Group Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Realcan Pharmaceutical Group Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Realcan Pharmaceutical Group Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Realcan Pharmaceutical Group Co stock

What is the Return on Assets (ROA) of Realcan Pharmaceutical Group Co this year?

The Return on Assets (ROA) of Realcan Pharmaceutical Group Co is 0 undefined this year.

What was the ROA of Realcan Pharmaceutical Group Co compared to the previous year?

The ROA of Realcan Pharmaceutical Group Co has increased by -101.22% compared to the previous year.

What consequences do high ROA have for investors of Realcan Pharmaceutical Group Co?

A high ROA is advantageous for investors of Realcan Pharmaceutical Group Co, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Realcan Pharmaceutical Group Co?

A low ROA can be unfavorable for investors of Realcan Pharmaceutical Group Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Realcan Pharmaceutical Group Co affect the company?

An increase in ROA of Realcan Pharmaceutical Group Co can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Realcan Pharmaceutical Group Co impact the company?

A reduction in the ROA of Realcan Pharmaceutical Group Co can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Realcan Pharmaceutical Group Co?

Some factors that can influence the ROA of Realcan Pharmaceutical Group Co include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Realcan Pharmaceutical Group Co important for investors?

The ROA of Realcan Pharmaceutical Group Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Realcan Pharmaceutical Group Co take to improve ROA?

To improve ROA, Realcan Pharmaceutical Group Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Realcan Pharmaceutical Group Co pay?

Over the past 12 months, Realcan Pharmaceutical Group Co paid a dividend of 0.01 CNY . This corresponds to a dividend yield of about 0.34 %. For the coming 12 months, Realcan Pharmaceutical Group Co is expected to pay a dividend of 0.01 CNY.

What is the dividend yield of Realcan Pharmaceutical Group Co?

The current dividend yield of Realcan Pharmaceutical Group Co is 0.34 %.

When does Realcan Pharmaceutical Group Co pay dividends?

Realcan Pharmaceutical Group Co pays a quarterly dividend. This is distributed in the months of July, July, August, July.

How secure is the dividend of Realcan Pharmaceutical Group Co?

Realcan Pharmaceutical Group Co paid dividends every year for the past 0 years.

What is the dividend of Realcan Pharmaceutical Group Co?

For the upcoming 12 months, dividends amounting to 0.01 CNY are expected. This corresponds to a dividend yield of 0.34 %.

In which sector is Realcan Pharmaceutical Group Co located?

Realcan Pharmaceutical Group Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Realcan Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Realcan Pharmaceutical Group Co from 6/4/2024 amounting to 0.013 CNY, you needed to have the stock in your portfolio before the ex-date on 6/4/2024.

When did Realcan Pharmaceutical Group Co pay the last dividend?

The last dividend was paid out on 6/4/2024.

What was the dividend of Realcan Pharmaceutical Group Co in the year 2023?

In the year 2023, Realcan Pharmaceutical Group Co distributed 0.018 CNY as dividends.

In which currency does Realcan Pharmaceutical Group Co pay out the dividend?

The dividends of Realcan Pharmaceutical Group Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Realcan Pharmaceutical Group Co

Our stock analysis for Realcan Pharmaceutical Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Realcan Pharmaceutical Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.